WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Andreas Laustsen
PeerJ Author
170 Points

Contributions by role

Author 135
Preprint Author 35

Contributions by subject area

Bioinformatics
Biotechnology
Toxicology
Immunology
Synthetic Biology

Andreas H Laustsen

PeerJ Author

Summary

Andreas Hougaard Laustsen is specialized in antibody discovery, toxinology, and snakebite antivenom. PhD from the University of Copenhagen. M.Sc.Eng. from the Technical University of Denmark. Co-founder of Biosyntia, VenomAb, Antag Therapeutics, Chromologics, and Bactolife. Recognized as Denmark’s Coolest Engineer, Top 10 Biotech Entrepreneur under 30 in Europe 2016, Top 6 Entrepreneurial Academic under 35 in Europe 2017, 30 under 30 by Forbes 2017, and a Top 35 Innovator under 35 by MIT Technology Review 2017

Bioengineering Biotechnology Immunology Molecular Biology Parasitology Pharmacology Toxicology Virology

Past or current institution affiliations

Technical University of Denmark
University of Copenhagen

Work details

Associate Professor

Technical University of Denmark
January 2018
Department of Biotechnology and Biomedicine
Tropical Pharmacology & Biotherapeutics

Websites

  • Tropical Pharmacology Lab

PeerJ Contributions

  • Articles 1
  • Preprints 1
January 24, 2017
Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2 from the Central American coral snake, Micrurus nigrocinctus
Andreas H. Laustsen, Mikael Engmark, Christopher Clouser, Sonia Timberlake, Francois Vigneault, José María Gutiérrez, Bruno Lomonte
https://doi.org/10.7717/peerj.2924 PubMed 28149694
August 17, 2016 - Version: 1
Exploration of immunoglobulin transcriptomes from mice immunized with three-finger toxins and phospholipases A2 from the Central American coral snake, Micrurus nigrocinctus
Andreas H Laustsen, Mikael Engmark, Christopher Clouser, Sonia Timberlake, Francois Vigneault, José María Gutiérrez, Bruno Lomonte
https://doi.org/10.7287/peerj.preprints.2364v1